Sep 30, 2019
1:4
For every 4 shares held, investors received 1. The price per share adjusted from $0.51 to $0.13.
The split itself did not change the total investment value.
Relmada Therapeutics, Inc. (RLMD) trades on the NASDAQ in the Biotechnology industry.
Relmada Therapeutics, Inc. company overviewThe latest split shown was on September 30, 2019. It was a 1-for-4 reverse split, so shareholders received 1 share for every 4 they held.
This history records 2 reverse splits between August 12, 2015 and September 30, 2019.